Introduction
Alzheimer’s disease (AD) is a neurodegenerative disorder leading to a progressive decline in cognitive function that is characterized at the molecular level by β-amyloid (Aβ)-induced synaptic dysfunction, neuronal loss, tau pathology, and oxidative stress (Verkhratsky et al. 2010). Reactive gliosis, including microglia activation and astrocyte reactivation, plays a significant role in the pathogenesis of AD, both in transgenic rodent models and human patients [
1,
2]. During the onset of AD, abnormal Aβ metabolism has a profound effect on the local community of neurons and glial cells in the central nervous system (CNS), while in the developmental stage of disease, the inflammatory response of reactive glial cells contributes to neuronal Ca
2+ dysregulation.
In neurons, Aβ peptides induce neurotoxic effects that are mediated via deregulation of intracellular calcium ([Ca
2+]
i) homeostasis, which results in synaptic loss. However, little is known about the role of Aβ in the regulation of astrocytic Ca
2+ homeostasis and subsequent pathological influences. Stimulation of Aβ in primary astrocytes triggers elevations in [Ca
2+]
i and the formation of reactive oxygen species, which are associated with metabolic failure of astrocytes and may directly induce neuronal loss [
3‐
5]. Notably, spontaneous [Ca
2+]
i accumulation has been identified in astrocytes of amyloid precursor protein/presenilin 1 (APP/PS1) mice in vivo, independent of neuron hyperactivity [
6].
The endoplasmic reticulum (ER) regulates [Ca
2+]
i homeostasis and protein folding. Store-operated Ca
2+ entry (SOCE) channels, which are complexes composed of stromal interaction molecule 1 (STIM1, an ER calcium sensor) and calcium release-activated calcium channel protein 1 (Orai1, a pore-forming protein), can be activated by the depletion of Ca
2+ stores in the ER [
7]. SOCE plays an essential role in the activation of non-excitable cells, including astrocytes and microglia, via triggering Ca
2+ influx [
8]. Disruption of protein folding in the ER triggers the unfolded protein response (UPR) via activation of three ER pathways: inositol-requiring enzyme 1 (IRE1), activating transcription factor 6 (ATF6), and PKR-like ER kinase (PERK) [
9,
10]. The 78-kDa glucose-regulated protein (GRP78) dissociates from PERK, ATF6, and IRE1 during ER stress, and then initiates proapoptotic signaling via activation of the CCAAT/enhancer-binding protein homologous protein (CHOP). Accumulating evidence suggests that Ca
2+-dependent ER stress is correlated with reactive astrogliosis (RA) in both an AD mouse model and ischemic stroke [
11,
12]. In addition, the intermediate-conductance Ca
2+-activated K
+ channel KCa3.1 is reported to be involved in cisplatin-initiated acute kidney injury [
13] and the phenotypic switch of RA in ischemic stroke [
12] via attenuation of ER stress.
KCa3.1 regulates K
+ efflux and subsequent Ca
2+ entry via hyperpolarization of the membrane potential [
14]. The KCa3.1 channel has been investigated as a therapeutic target in neurodegeneration diseases, vascular restenosis, and autoimmune diseases [
15‐
17]. Our group recently reported that KCa3.1 inhibition significantly ameliorated neuronal loss, RA, microglial activation, and memory deficits in both APP/PS1 mice and senescence-accelerated mouse prone 8 (SAMP8) mice [
15,
18]. KCa3.1 also plays a key role in mediating Aβ-induced RA, which includes activation of the mitogen-activated protein kinase/c-Jun N-terminal kinase (MAPK/JNK) signaling pathway and upregulation of reactive oxygen species (ROS) production. Blockade of KCa3.1 channels with triarylmethane-34 (TRAM-34) was shown to attenuate microglial-dependent indirect neurotoxicity in vivo, which emphasizes the role of Ca
2+ in the process of neuroinflammation [
19,
20]. Collectively, these data clearly demonstrate that KCa3.1 presents a potential therapeutic target in AD.
Therefore, the aim of present study was to elucidate the underlying mechanisms of Aβ-mediated ER stress in RA and to identify key molecules involved in the regulation of RA-induced neurotoxicity. We report that Ca2+ overload induces ER stress in primary astrocytes and ER stress is increased in AD patients and APP/PS1 AD mice. Blockade or gene deletion of KCa3.1 decreased SOCE-induced Ca2+ overload and attenuated ER stress via the protein kinase B/mechanistic target of rapamycin (AKT/mTOR) pathway in primary astrocytes, which is essential to protect neurons against RA-induced neurotoxicity. We also show that the absence of KCa3.1 channels attenuated ER stress, gliosis, neuroinflammation, memory deficits, and neuronal loss in KCa3.1−/−/APP/PS1 mice. These results reveal an important correlation between KCa3.1 activation and cognitive deficits in APP/PS1 AD mice, suggesting that KCa3.1 may be an effective therapeutic target in AD.
Materials and methods
Brain autopsy material
Frozen tissues and paraffin-embedded brain slices from the hippocampi of postmortem human samples of control and AD patients were obtained from the Netherlands Brain Bank (Netherlands Institute for Neuroscience, Amsterdam, Netherlands). The Netherlands Brain Bank obtained written informed consent for brain autopsy specimens for research purposes after death. The Braak stage, neuropathological and clinical diagnoses, age and gender distributions, as well as diagnostic groupings are presented in Table
1. The frozen tissues were used to isolate proteins, and expression of proteins was evaluated by Western blotting as described below. Immunofluorescence was performed on 8-μm sections using antibodies against glial fibrillary acidic protein (GFAP), KCa3.1, Orai1, and GRP78 antibodies as described below.
Table 1
Demographic data of the cases studied
Control-1 | F | 73 | 0 | B | E3/E2 | WB, IF |
Control-2 | M | 99 | 2 | C | – | WB, IF |
Control-3 | F | 81 | 1 | O | E3/E3 | WB, IF |
Control-4 | F | 89 | 2 | B | – | WB, IF |
Control-5 | M | 84 | 2 | A | – | WB, IF |
Control-6 | F | 64 | 0 | A | E3/E2 | WB, IF |
AD-1 | F | 81 | 6 | C | E4/E3 | WB, IF |
AD-2 | F | 62 | 6 | C | E4/E3 | WB, IF |
AD-3 | M | 84 | 6 | C | – | WB, IF |
AD-4 | F | 72 | 6 | C | E3/E2 | WB, IF |
AD-5 | F | 89 | 6 | C | E4/E3 | WB, IF |
AD-6 | M | 96 | 6 | C | – | WB, IF |
Animals
Wild-type (WT) C57BL/6 mice (male, 25–30 g) were procured from the Shanghai Laboratory Animal Center (Shanghai, China). KCa3.1
−/− mice were obtained from the Jackson Laboratory (Bar Harbor, ME, USA) and housed as described previously [
18]. APP/PS1 transgenic mice (an AD model) were also purchased from the Jackson Laboratory (no. 003378) [
15]. KCa3.1
−/− mice were crossed with APP/PS1 mice and the offspring were intercrossed to generate mice with the KCa3.1
−/−/APP/PS1 genotype. Mouse cohorts of the four genotypes (WT, KCa3.1
−/−, KCa3.1
−/−/APP/PS1, and APP/PS1) were generated and used for behavioral analysis. The protocols of all animal experiments were approved by the Animal Experimentation Ethics Committee of Shanghai Jiao Tong University School of Medicine, Shanghai, China (ethics protocol number: A-2015-010).
Morris water maze test
The modified Morris water maze (MWM) test was performed as previously described [
21]. Briefly, the test requires the mice to receive 5 consecutive training days (1 day with the visible platform and 4 days with the hidden platform) in a circular water tank (diameter = 80 cm; height = 50 cm) containing opaque water (22 °C, 25 cm deep). A spatial probe trial was performed on day 6 with no platform present. During the hidden platform training days, the mice were allowed to swim for 60 s to find the hidden platform (1 cm below the water surface). The platform was removed from the pool on day 6 of the spatial probe trial and the mice swam freely for 60 s. Performance of the MWM test was recorded using a video camera and analyzed using a video tracking system (Jiliang Software Technology Co., Ltd., Shanghai, China).
Immunostaining and data analysis
Confocal microscopy was performed as previously described [
18]. Briefly, mice were anesthetized with chloral hydrate and perfused with 4% paraformaldehyde. Then, 10% goat serum in 0.01 M phosphate-buffered saline (PBS) was used to block 12-μm sections of the mice brain or 8-μm sections of the human brain for 1 h at room temperature. The brain sections were then incubated with the following primary antibodies: rabbit anti-GFAP (1:1000; Dako, Glostrup, Denmark), mouse anti-GFAP (1:200; Merck Millipore, Burlington, MA, USA), rabbit anti-NeuN (1:100; Merck Millipore, Burlington, MA, USA), rabbit anti-Iba1 (1:500; Wako Pure Chemical Industries, Ltd., Osaka, Japan), mouse anti-KCa3.1 (1:100; Alomone Labs, Ltd., Jerusalem, Israel), rabbit anti-GRP78 (1:100; Cell Signaling Technology, Inc., Beverly, MA, USA), mouse anti-NG2 (Sigma-Aldrich Corporation, St. Louis, MO, USA), and rabbit anti-Orai1 (1:100; Santa Cruz Biotechnology, Inc., Dallas, TX, USA). After incubation at 4 °C overnight, the brain sections were incubated with the respective Alexa Fluor® 488- or 568-conjugated secondary antibodies (1500; Invitrogen Corporation, Carlsbad, CA, USA). Images were collected using a TCS SP8 confocal laser scanning microscope (Leica Microsystems, Wetzlar, Germany) and processed with Leica LASAF Lite imaging software. The same reference position was used for each brain slice for quantification, i.e., between three and five random 0.01-mm
2 microscopic fields. Quantification was measured from six sections per brain (120-μm intervals) in a blinded manner.
Western blot analysis
Mice were anesthetized with chloral hydrate and perfused with saline. Mice or human brain tissues and cells were lysed on ice with radioimmunoprecipitation assay buffer (50 mM Tris (pH 7.4), 150 mM NaCl, 1% Triton X-100; 1% sodium deoxycholate, 0.1% sodium dodecyl sulfate, sodium orthovanadate, sodium fluoride, ethylenediaminetetraacetic acid, leupeptin) containing 1% phenylmethanesulfonyl fluoride. The supernatants were collected after centrifuging at 13,500 rpm for 5 min at 4 °C. Equal concentrations of proteins were separated by 10% (w/v) sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then transferred to a polyvinylidene difluoride membrane, which was blocked for 1 h at room temperature (RT) in 5% milk in Tris-buffered saline with 0.05% Tween 20. The membrane was incubated with the following primary antibodies overnight at 4 °C: mouse anti-KCa3.1 (1:100; Alomone Labs, Ltd.), mouse anti-STIM1 (1:500; Santa Cruz Biotechnology, Inc.), rabbit anti-Orai1 (1:1000; Santa Cruz Biotechnology, Inc.), rabbit anti-GRP78, rabbit anti-mTOR, rabbit anti-phospho-mTOR (Ser2448), rabbit anti-phospho-PERK (Thr980), rabbit anti-phospho-eIF2α, rabbit anti-phospho-Akt (Thr308), rabbit anti-Akt, rabbit anti-phospho-4E-BP1, rabbit anti-phospho-p70 S6 Kinase, mouse anti-CHOP, rabbit anti-iNOS, rabbit anti-COX2 (1:1000; Cell Signaling Technology), and mouse anti-β-actin (1:1000; Beyotime Institute of Biotechnology, Haimen, China). The membranes were subsequently washed and incubated with anti-rabbit or anti-mouse HRP for 1 h at RT, and developed using BeyoECL solution (P0018A; Beyotime Institute of Biotechnology). Image Studio Lite Ver 5.2 software (LI-COR Biosciences, Lincoln, NE, USA) was used to analyze the proteins.
Enzyme-linked immunosorbent assay
ELISA was performed using the kit for TNF-α and IL-1β (Rapidbio Labs, Langka Trade Co. Ltd., Shanghai, China). The procedures were conducted according to manufacturer’s protocols.
Preparation of oligomeric Aβ peptides
The oligomeric Aβ was prepared as described previously (Yi et al. 2016b). Briefly, monomeric peptide Aβ was dissolved in 1,1,1,3,3,3-hexafluoro 2-propanol (Sigma-Aldrich Corporation, St. Louis, MO, USA) at 1 mg/mL. The dried monomeric peptide Aβ was resolved in ddH2O at a concentration of 100 mM and incubated at 4 °C for 24 h to induce aggregation.
Primary cultures
Primary cortical astrocyte cultures derived from newborn (P0–P2) WT or KCa3.1
−/− C57BL/6 mouse brains were prepared from mixed glial cultures (10–14 days in vitro) as described previously [
22]. Briefly, the cerebral cortices were dissociated into single cell suspensions. Dissociated single cells were grown in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal bovine serum at 37 °C under an atmosphere of 5% CO
2. When the astrocytes grew to confluence (10–14 days later), the flasks were shaken overnight (200 rpm, 37 °C) to deplete microglia and oligodendrocytes. The purified astrocytes were then plated onto 6-well or 96-well plates in serum containing medium. Astrocytes were incubated with serum-free DMEM for 24 h after reaching confluence again
, and then were treated with Aβ for different time periods before harvest. The culture medium (CM) was changed to neurobasal medium (NB) with B27 supplement (Invitrogen Corporation) after confluent astrocytes were serum-free for 24 h. The NB/B27-based WT and KCa3.1
−/− astrocytes were then treated with 5 μM Aβ oligomer. The CM from the NB/B27-based cells was collected and used immediately. The primary cultured cortical neurons were isolated from neonatal (P0–P2) C57BL/6 mice and cultured as described previously (Yi et al. 2016b).
Neurite outgrowth assay
Cells were stained with primary antibody against microtubule-associated protein 2 (MAP2) and Alexa Fluor® 568-conjugated secondary antibody. A Cellomics Kinetic Scan reader (Thermo Fisher Scientific, Waltham, MA, USA) was used to scan the MAP2-positive cells. Extended Neurite Outgrowth software (Thermo Fisher Scientific) was used to analyze the data.
Calcium imaging
The purified astrocytes were plated in the wells of 96-well plates containing DMEM supplemented with 10% fetal bovine serum. After once again reaching confluence, the cells were incubated with the fluorescent calcium indicator Fluo-4AM (1.6 μM; Beyotime Institute of Biotechnology) for 25 min and then washed three times with 0.01 M PBS. Afterward, 2 μM ethylene glycol-bis (β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid was used to chelate the calcium in the DMEM and then 1 μM thapsigargin (Tg) was used to induce [Ca2+]i release. After the [Ca2+]i concentration was stable, 2 mM CaCl2 solution was added to the DMEM to induce Ca2+ influx. Fluorescence signals were recorded and analyzed using a FlexStation 3 Multi-Mode Microplate Reader (Molecular Devices, Sunnyvale, CA, USA).
Statistical analysis
All data are presented as the mean ± standard error of the mean. Statistical analyses were performed using Prism software (GraphPad Software, Inc., La Jolla, CA, USA). Data were tested for Gaussian distribution with the Kolmogorov–Smirnov normality test and then analyzed by one-way analysis of variance (ANOVA) and the Dunnett’s post-hoc test. Data were analyzed with an unpaired, two-tailed Student’s t test when comparing between two groups or the non-parametric Mann–Whitney test was applied. Statistical significance was set at p < 0.05.
Discussion
The importance of KCa3.1 channels to CNS function is underscored by a series of studies implicating KCa3.1 in various diseases, including stroke/ischemia [
32,
33], AD [
11,
15], traumatic brain injury [
34], and spinal cord injury [
35]. These studies showed that upregulation of KCa3.1 activity can profoundly influence CNS pathology. Here, we report that KCa3.1 expression was markedly associated with ER stress and UPR in both Aβ-stimulated primary astrocytes and brain lysates of AD patients and APP/PS1 AD mice. Gene deletion or blockade of KCa3.1 attenuated SOCE-induced Ca
2+ overload and ER stress, which regulates the AKT/mTOR pathway in RA to protect neurons from RA-induced neurotoxicity. Elimination of KCa3.1 can attenuate ER stress, neuronal loss, gliosis, neuroinflammation, and memory deficits observed in KCa3.1
−/−/APP/PS1 mice. These data suggest that KCa3.1 presents an effective therapeutic target in AD.
Astrocytes perform brain homeostatic maintenance within the CNS and communicate with neighboring neurons and glial cells via [Ca
2+]
i signals triggering the gliotransmitters release [
3,
36‐
40]. SOCE channels, composed of STIM1 and Orai1 (pore-forming proteins), can be activated by the depletion of Ca
2+ stores in the ER [
7]. SOCE, which is regulated by STIM1/2 and Orai1, plays an essential role in the activation of non-excitable cells, including astrocytes and microglia, via triggering Ca
2+ influx [
8]. STIM1/2 and Orai1 were identified as key molecules of SOCE in cortical and spinal astrocytes. SOCE plays an important role in the production of the cytokines tumor necrosis factor-α and interluekin-6 in spinal astrocytes in response to lipopolysaccharides [
27].
Dysfunctional astrocytic Ca
2+ signaling is involved in many pathological states, such as epilepsy and ischemia [
41]. Vincent et al. reported that astrocytic Ca
2+ homeostasis is disrupted in AD. Disruption of Ca
2+ signaling of astrocytes was found both in the transgenic mouse models of AD in vivo and in Aβ-stimulated primary astrocytes in vitro [
5,
6,
42,
43]. ER stress plays an important role in the pathophysiology of various neurodegenerative diseases, including AD [
44,
45]. Much evidence indicates a relationship between ER stress and Aβ-induced cytotoxicity in the post-mortem brain tissue of AD patients and AD mouse models [
45,
46]. Aβ severely disrupts ER function and induces ER stress in neurons and glial cells [
25,
47]. Stimulation with Aβ oligomers deregulated ER Ca
2+ homeostasis in neurons and astrocytes, which resulted in misfolding of proteins in the ER. Excessive and prolonged activation of ER stress may initiate apoptosis by regulation of several key proteins, including CHOP, caspase-12, and JNK, which can further aggravate Aβ cytotoxicity [
48]. ER stress is reportedly linked with some inflammation signaling networks, suggesting that ER stress activation may be involved in the neuroinflammatory response [
49]. In the present study, we demonstrated that Aβ induced ER stress in astrocytes in vitro and observed upregulation of CHOP and the ER-resident chaperone GRP78 [
50,
51]. Gene deletion and pharmacological blockade of KCa3.1 were shown to attenuate the upregulation of UPR hallmarks.
APP/PS1 mice present the prodromal phase of AD, reflecting memory and spatial learning deficits, as assessed by performance in the MWM test [
52]. Soluble and plaque-associated Aβ peptides, which are present starting at 6 months of age in APP/PS1 transgenic mice, induce ER stress and sequent phosphorylation of PERK and eIF2a, which are closely associated with the pathogenesis of AD [
53]. The results of the present study also suggest that elimination of KCa3.1 ameliorated the pathological hallmarks of AD in KCa3.1
−/−/APP/PS1 mice, such as neuronal loss, microglial activation, and RA. Although the mechanisms underlying the attenuation of memory deficits by elimination of KCa3.1 are not well known, they are likely associated with the decreased pathological markers noted in KCa3.1
−/−/APP/PS1 mice, as compared with APP/PS1 mice. Similar to AD patients, phosphorylation of GRP78 and eIF2α is upregulated in the brains of APP/PS1 mice [
54]. APP/PS1 mice also showed decreased expression of NeuN and increased expression of Iba1 and GFAP, suggesting the presence of neuronal loss, microglial activation, and RA. Brain slices of KCa3.1
−/−/APP/PS1 mice showed significantly lower levels of these markers than those of APP/PS1 mice, indicating that KCa3.1 gene deletion might involve in ER stress and, thereby, attenuate neuronal loss and glia inflammation in AD mice.
Our data also demonstrated that KCa3.1 regulates ER stress via the downstream AKT/mTOR signaling pathway during RA in AD. We observed that Aβ decreased the activation of AKT by decreasing AKT phosphorylation in primary astrocytes. Interestingly, KCa3.1 elimination prevented Aβ-mediated loss of AKT activation via upregulation of AKT phosphorylation at Thr308. Growing evidence indicates that the mTOR signaling pathway plays a vital role during apoptosis and autophagy. Our results show that Aβ represses the phosphorylation of AKT, mTOR, p70 S6 kinase, and 4EBP1, and that a decrease in the phosphorylation of AKT led to UPR activation. The postmortem brain samples from patients with and without AD were also evaluated. The results indicate that KCa3.1 expression and activation of UPR-associated proteins are increased in the brains of AD patients.